Loading clinical trials...
Loading clinical trials...
An observational study to assess the effectiveness, health economic-relevant costs and participant reported outcomes in participants with Chronic lymphocytic leukemia (CLL) receiving venetoclax as a m...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
AbbVie
NCT07030400 · Small Lymphocytic Lymphoma (SLL), Chronic Lymphocytic Leukemia (CLL)
NCT06043011 · Chronic Lymphocytic Leukemia (CLL), Diffuse Large B-cell Lymphoma (DLBCL), and more
NCT06528301 · Lymphoma, B-Cell, Lymphoma, Non-Hodgkin (NHL), and more
NCT05168930 · Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL)
NCT05643742 · B-cell Lymphoma, Non-Hodgkin Lymphoma, and more
Universitaetsklinikum St. Poelten /ID# 221152
Sankt Pölten, Lower Austria
Medizinische Universitaet Graz /ID# 221155
Graz, Styria
Landeskrankenhaus Salzburg-Universitaetsklinikum der PMU (LKH) /ID# 221153
Salzburg
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions